Australia: Epileptic NSW Children to Trial Cannabis
NSW children suffering severe, debilitating and treatment-resistant epilepsy will soon be able to access medicinal cannabis as part of an Australian-first clinical trial.
The experimental, cannabis-based Epidiolex drug will be delivered through the Sydney Children's Hospital to an initial group of 40 NSW families in need, with the hope of expanding the trial to hundreds within the next 12 months.
"This is a day we give hope to some of the sickest kids in NSW," Mike Baird told reporters in Sydney on Tuesday.
The NSW Premier said while the drug was still in the final stages of development across the world, it was beginning to yield staggering results where other forms of treatment had failed.
"For three out of 10 there is a significant benefit, a significant improvement in their condition," he said.
"And for one out of 10, it's miraculous."
Mr Baird cautioned the medicine would not work for...
This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.
Follow us on Instagram
Connect with us on Linkedin